Current Report · Items 1.01 · 8-K
JOINT Corp
Entry into a Material Definitive Agreement
Item 1.01. Entry Into a Material Definitive Agreement. On October 1, 2026, we entered into an Asset Purchase Agreement (the “APA”) with The Joint Franchises San Antonio, LLC, a Texas limited liability company, The Joint Franchises DFW, LLC, a Texas limited liability company, The Joint Franchises Houston, LLC, a Texas limited liability company, The Joint Franchises Austin, LLC, a Texas limited liab…
Filed Oct 1, 2026Accepted Oct 1, 2026, 6:38 AM EDTCIK 1612630Accession 0001612630-26-000071
Company context
Current securities
Registered securities in this filing
Joint Corp. · 8-K · Filed 2026-10-01
As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.
Common Stock, $0.001 Par Value Per Share
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Filing context
Context: c-1
Dimensions: Not supplied
Accession 000161263026000071 · 1 registered-security cover member
Read the exact SEC filing ↗Disclosure sections
Items 1.01Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 1.01Item 1.01 - Entry into Material Agreement
Item 1.01. Entry Into a Material Definitive Agreement.
On October 1, 2026, we entered into an Asset Purchase Agreement (the “APA”) with The Joint Franchises San Antonio, LLC, a Texas limited liability company, The Joint Franchises DFW, LLC, a Texas limited liability company, The Joint Franchises Houston, LLC, a Texas limited liability company, The Joint Franchises Austin, LLC, a Texas limited liability company, and The Joint Franchises Texas, Ltd., a Texas limited partnership, of which David Glover and Anne Glover, residents of Texas, are the limited partners (referred to collectively as the “Sellers” and individually as a “Seller”), pursuant to which effective at 12:01 a.m. on October 1, 2026, we will reacquire from the Sellers certain regional development rights in the Texas region, and mutually terminate the related regional developer agreements with the Sellers in the Texas region (collectively, the “Texas RDAs”). As of October 1, 2026, the Texas region includes 141 franchised clinics and following the transaction, the Sellers will continue to franchise eight clinics in Texas through their affiliates.
The Texas RDAs are among the Company’s earliest regional developer agreements and included certain negotiated terms such as renewal rights for multiple successive 10-year terms. Pursuant to the Texas RDAs, the Sellers received approximately $2.3 million in royalties paid by franchisees in the Texas region during the trailing twelve months ended August 31, 2026. Based on the foregoing, the aggregate purchase price we will pay to Seller is $8.0 million in cash due upon execution of the agreement, and if certain gross sales metrics are met or exceeded under these Texas RDAs during the two annual periods beginning September 1, 2026, up to $2.0 million in additional consideration payments, split evenly between the two years.
The APA also contains other provisions, covenants, representations, and warranties that are typical in transactions of this size, type, and complexity.
The description of the APA does not purport to be complete, and such description is qualified in its entirety by reference to the complete terms of the APA, which will be filed as an exhibit to our Annual Report on Form 10-K.